Creighton’s Hereditary Cancer Center makes groundbreaking discoveries in cancer research
It’s difficult for Robin Farias-Eisner, M.D., Ph.D., to condense decades of cancer research into a single conversation. But recent developments call for brevity.
Sitting in his office on the second floor of the Hixson-Lied Science Building, Farias-Eisner, the newest director of Creighton University’s Hereditary Cancer Center, explains how he and a team of researchers have discovered a new drug with the potential to treat a broad array of illnesses, including ovarian cancer, colon cancer, macular degeneration, heart disease and more.
“It would be hard to overstate it,” Farias-Eisner says of the potential impact of the find.